MedPath

Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer

Completed
Conditions
Sexual Dysfunction, Physiological
Sexual Dysfunctions, Psychological
Urinary Bladder Neoplasms
Hematuria
Erectile Dysfunction
Registration Number
NCT02381912
Lead Sponsor
Herlev Hospital
Brief Summary

The purpose of the study is to investigate sexual function in patients suspected of non muscle invasive bladder cancer (NMIBC). The investigators hypothesis is that reduced sexual function is underdiagnosed in patients with non-muscle invasive bladder cancer and that active examination and treatment may worsen the sexual function.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
210
Inclusion Criteria
  • Patients with primary hematuria, both gross and microscopic
  • Men and women older or equal to 40 years of age
  • Signed informed consent statement
Exclusion Criteria
  • Men and women younger than 40 years of age
  • Patients with recurrent hematuria and known causative disease
  • Already known urogenital cancer
  • Previous massive pelvic surgery or pelvic radiotherapy
  • TUR-P within the last 2 months
  • Participants diagnosed with tumors originating from the ureters, renal pelvis and kidney, and bladder tumors at T stage more than or equal to T1b.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in sexual function4 months

Change in sexual function measured by the "EORTC QLQ-BLS24 sexual functioning questions"

Secondary Outcome Measures
NameTimeMethod
Change in erectile function4 months

Change in erectile function measured by the Erection Hardness Scale

Trial Locations

Locations (1)

Herlev Hospital

🇩🇰

Herlev, Denmark

Herlev Hospital
🇩🇰Herlev, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.